Allergan / Inamed / Natrelle
On December 18, 2018, Allergan Biocell implants were withdrawn from the market due to the increased risk of ALCL (cancer) >>
McGhan BioDimensional Silicone-Filled Biocell Textured Breast Implants
McGhan Magna-Site Tissue Expander
McGhan Style 134 Croissant Shaped Tissue Expander
Natrelle 133 Plus Issue Expanders
Natrelle 133 Tissue Expanders with and without suture tabs
Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
Natrelle Inspira Silicone-Filled Breast Implants
Natrelle Saline Breast Implants
Natrelle Silicone-Filled Breast Implants
Style 133 Biospan Tissue Expander
Although Allergan / Natrelle 410 implants were approved in 2006, our organization received many reports of rupture and leakage from them. Some women reported ruptures within 2 and 3 years!
Directions for use Allergan >>
Safety and efficacy have not been established in patients with:
• Autoimmune diseases (such as lupus and scleroderma).
• A weakened immune system (for example, in immunosuppressive therapy).
• Conditions or medications that interfere with wound healing and blood clotting.
• Reduced blood supply to the breast tissue.
• Radiation therapy for breast cancer if you are wearing implants
• Clinical diagnosis of depression or other mental disorders, including body disorder and eating disorders.
Discuss any history of mental disorders prior to surgery.
Patients with a diagnosis of depression or other mental disorders, have to wait until resolution or stabilization
of these conditions to the undergoing breast implant surgery.
The FDA about complications of Allergan / Inamed implants . >>
No new implants with symptoms >>